This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kjeldsen, S. E. Articles by Julius, S. Search for Related Content PubMed PubMed Citation Articles by Kjeldsen, S. E. Articles by Julius, S.

(Hypertension. 1995;25:1096-1105.)
© 1995 American Heart Association, Inc.

Articles

Effect of Circulating Epinephrine on Platelet Function and Hematocrit

Sverre E. Kjeldsen; Alan B. Weder; Brent Egan; Richard Neubig; Andrew J. Zweifler; Stevo Julius

From the Department of Internal Medicine, Ullevaal University Hospital, Oslo, Norway (S.E.K.); Division of Hypertension, University of Michigan, Ann Arbor (A.B.W., R.N., A.J.Z., S.J.); and Division of Clinical Pharmacology, Medical University of South Carolina, Charleston (B.E.).

Abstract We investigated the effect of raising arterial plasma epinephrine within the lower pathophysiological concentration range on various indicators of blood platelet function and hematocrit. Epinephrine was raised over 60 minutes by a stepwise increasing intravenous infusion in 40 healthy men aged 20 to 40 years. Platelet count increased progressively with increasing arterial epinephrine to a maximal change of 69±6 x10⁹/L in EDTA-anticoagulated blood and a maximal change of 42±6 x10⁹/L in acid-citrate-dextrose (ACD)–anticoagulated blood, and the weight of circulating platelets increased by 29% (P<.001). Platelet size increased significantly in EDTA and decreased in ACD, and the difference between EDTA and ACD was significant (P<.0001) for both count and size, suggesting that epinephrine not only recruits platelets into the circulation but also induces some microaggregation in vivo or adhesion ex vivo. Aggregation of platelets in vitro induced by epinephrine decreased (P<.003 for optical density and P=.038 for maximal optical density) after epinephrine infusion compared with saline but did not change when stimulated with ADP or collagen. These findings suggest a selective downregulation of the epinephrine-activating mechanisms concomitant with a rise in the platelet content of epinephrine by 81% (P<.001) and no change in the platelet sodium-proton membrane exchange. The release of granular content (ß-thromboglobulin and platelet factor 4) to the circulation in response to epinephrine was not significant. Thus, under acute conditions it seems that the platelets may protect themselves against inappropriate overstimulation by epinephrine. The importance of platelet epinephrine uptake is still unknown, but sodium-proton exchange does not seem to be involved in regulating the effects of circulating epinephrine on platelet function. Epinephrine has a pronounced effect on raising hematocrit (maximal change of 1.74±0.13 x10^-2, P<.0001).

Key Words: catecholamines • hypertension, essential • dopamine • norepinephrine • platelet aggregation • stress • thrombosis

This article has been cited by other articles:

				H. Ay, E. M. Arsava, W. J. Koroshetz, and A. G. Sorensen Middle Cerebral Artery Infarcts Encompassing the Insula Are More Prone to Growth Stroke, February 1, 2008; 39(2): 373 - 378. [Abstract] [Full Text] [PDF]

				S. W. Olson, L. E. Deal, and M. Piesman Epinephrine-Secreting Pheochromocytoma Presenting with Cardiogenic Shock and Profound Hypocalcemia Ann Intern Med, May 18, 2004; 140(10): 849 - 851. [Full Text] [PDF]

				A. Spalding, H. Vaitkevicius, S. Dill, S. MacKenzie, A. Schmaier, and W. Lockette Mechanism of Epinephrine-Induced Platelet Aggregation Hypertension, February 1, 1998; 31(2): 603 - 607. [Abstract] [Full Text] [PDF]